Real-time
Other stock markets
|
|
5-day change | 1st Jan Change | |
54.00 EUR | 0.00% | +0.19% | +6.51% |
Sep. 11 | Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sep. 07 | Oddo BHF Raises Boiron PT, Maintains Outperform Rating | MT |
Sales 2023 * | 543 M 570 M | Sales 2024 * | 568 M 597 M | Capitalization | 938 M 985 M |
---|---|---|---|---|---|
Net income 2023 * | 45 M 47 M | Net income 2024 * | 50 M 53 M | EV / Sales 2023 * | 1,20x |
Net cash position 2023 * | 285 M 300 M | Net cash position 2024 * | 266 M 279 M | EV / Sales 2024 * | 1,18x |
P/E ratio 2023 * | 20,6x | P/E ratio 2024 * | 18,6x | Employees | - |
Yield 2023 * | 2,00% | Yield 2024 * | 2,31% | Free-Float | 20.70% |
More Fundamentals
* Assessed data
More news
More press releases
More news
1 week | +0.19% | ||
Current month | +3.85% | ||
1 month | +4.25% | ||
3 months | +41.73% | ||
6 months | +34.83% | ||
Current year | +6.51% |
1 week
53.00
54.40

1 month
51.20
54.80

Current year
36.75
54.80

1 year
36.75
54.80

3 years
32.60
54.80

5 years
26.75
59.00

10 years
26.75
112.80

Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 2018 | |
Thierry Boiron
CHM | Chairman | 62 | 2011 |
Eric Lambert
SEC | Corporate Secretary | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Thierry Boiron
CHM | Chairman | 62 | 2011 |
Michéle Boiron
BRD | Director/Board Member | 78 | 1996 |
Director/Board Member | 79 | 2003 |
Date | Price | Change | Volume |
---|---|---|---|
23-09-27 | 54.00 | 0.00% | 5,938 |
23-09-26 | 54.00 | +0.93% | 4,864 |
23-09-25 | 53.50 | -1.47% | 3,239 |
23-09-22 | 54.30 | +0.74% | 15,020 |
23-09-21 | 53.90 | 0.00% | 7,201 |
Real-time Euronext Paris, September 27, 2023 at 11:35 am EDT
More quotes
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues.
Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin.
There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties).
BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries.
Net sales are distributed geographically as follows: France (52.4%), Europe (22.5%), North America (22.6%) and other (2.5%).
Sector
Pharmaceuticals
Calendar
2023-10-17
- Détachement de
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
Sell
Buy

Mean consensus
HOLD
Number of Analysts
3
Last Close Price
54.00EUR
Average target price
47.38EUR
Spread / Average Target
-12.26%
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. (M$) | |
---|---|---|
+6.51% | 991 M $ | |
+1.69% | 994 M $ | |
+7.96% | 976 M $ | |
-22.52% | 1 143 M $ | |
-18.90% | 807 M $ | |
+21.01% | 775 M $ | |
+2.55% | 1 268 M $ | |
+28.83% | 1 293 M $ | |
+25.42% | 1 294 M $ | |
-61.46% | 678 M $ |